0102030405
Trametinib (DMSO) Intermediates CAS NO 871700-25-3 Pharmaceutical Intermediates
02
introduce
N-{3-[3-Cyclopropyl-1-(2-Fluoro-4-Iodophenyl)-6,8-Dimethyl-2,4,7-Trioxo-1,2,3,4,7,8-Hexahydropyrido[2,3-d]pyrimidin-5-ylamino]phenyl}acetamide is a novel chemical compound that has garnered attention in the pharmaceutical industry due to its unique properties and potential therapeutic applications. This compound is characterized by its complex structure, which includes a cyclopropyl group, a fluorinated iodophenyl moiety, and a hexahydropyrido-pyrimidine core. Its intricate design enhances its biological activity, making it a promising candidate for drug development.
02
Physical and chemical properties
N-{3-[3-Cyclopropyl-1-(2-Fluoro-4-Iodophenyl)-6,8-Dimethyl-2,4,7-Trioxo-1,2,3,4,7,8-Hexahydropyrido[2,3-d]pyrimidin-5-ylamino]phenyl}acetamide possesses several key physical and chemical properties that enhance its utility in pharmaceutical applications:
- Molecular Formula: C26H23FIN5O4
- Molecular Weight: 615.39 g/mol
- Appearance: Typically presented as a white to off-white crystalline powder.
- Solubility: Soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, facilitating its use in various formulations.
- Stability: Exhibits good stability under standard laboratory conditions, making it suitable for long-term storage and use in diverse applications.
The advantages of N-{3-[3-Cyclopropyl-1-(2-Fluoro-4-Iodophenyl)-6,8-Dimethyl-2,4,7-Trioxo-1,2,3,4,7,8-Hexahydropyrido[2,3-d]pyrimidin-5-ylamino]phenyl}acetamide extend beyond its chemical properties, making it a preferred choice for researchers and pharmaceutical developers:
- Targeted Therapeutic Potential: The unique structure of this compound allows for selective interaction with specific biological targets, enhancing its potential as a therapeutic agent.
- High Bioactivity: This compound has demonstrated significant bioactivity in various preclinical studies, indicating its potential effectiveness in treating complex diseases, including cancer.
- Versatile Applications: N-{3-[3-Cyclopropyl-1-(2-Fluoro-4-Iodophenyl)-6,8-Dimethyl-2,4,7-Trioxo-1,2,3,4,7,8-Hexahydropyrido[2,3-d]pyrimidin-5-ylamino]phenyl}acetamide can be utilized in the development of a wide range of therapeutic agents, including those targeting oncology and other serious health conditions.
- Cost-Effective Solution: As a product of our integrated manufacturing process, we offer competitive pricing without compromising on quality.
N-{3-[3-Cyclopropyl-1-(2-Fluoro-4-Iodophenyl)-6,8-Dimethyl-2,4,7-Trioxo-1,2,3,4,7,8-Hexahydropyrido[2,3-d]pyrimidin-5-ylamino]phenyl}acetamide is increasingly recognized for its applications in the pharmaceutical industry, particularly in drug discovery and development:
- Oncology Research: The compound is being investigated for its potential to inhibit specific cancer cell pathways, making it a candidate for novel anticancer therapies.
- Therapeutic Development: N-{3-[3-Cyclopropyl-1-(2-Fluoro-4-Iodophenyl)-6,8-Dimethyl-2,4,7-Trioxo-1,2,3,4,7,8-Hexahydropyrido[2,3-d]pyrimidin-5-ylamino]phenyl}acetamide is also being explored for its effects on various biological pathways, with potential applications in treating conditions such as inflammation and metabolic disorders.
- Bioconjugation: Its reactive nature allows for the development of bioconjugates, enhancing the specificity and efficacy of drug delivery systems.
As an integrated manufacturing and trading factory, we prioritize quality and compliance in every aspect of our production process. Our facilities are equipped with advanced technology, and we adhere to Good Manufacturing Practices (GMP) to ensure that our products meet the highest standards of purity and potency. Rigorous quality control measures are implemented to guarantee that each batch of N-{3-[3-Cyclopropyl-1-(2-Fluoro-4-Iodophenyl)-6,8-Dimethyl-2,4,7-Trioxo-1,2,3,4,7,8-Hexahydropyrido[2,3-d]pyrimidin-5-ylamino]phenyl}acetamide is consistent and reliable.
N-{3-[3-Cyclopropyl-1-(2-Fluoro-4-Iodophenyl)-6,8-Dimethyl-2,4,7-Trioxo-1,2,3,4,7,8-Hexahydropyrido[2,3-d]pyrimidin-5-ylamino]phenyl}acetamide is a promising compound in the pharmaceutical industry, offering researchers and developers a powerful tool for drug discovery and development. Our commitment to quality, regulatory compliance, and continuous improvement positions us as a trusted partner in the pharmaceutical sector. By choosing N-{3-[3-Cyclopropyl-1-(2-Fluoro-4-Iodophenyl)-6,8-Dimethyl-2,4,7-Trioxo-1,2,3,4,7,8-Hexahydropyrido[2,3-d]pyrimidin-5-ylamino]phenyl}acetamide from our integrated factory, you are investing in a high-quality product that can significantly enhance your research and development efforts.
For more information about our N-{3-[3-Cyclopropyl-1-(2-Fluoro-4-Iodophenyl)-6,8-Dimethyl-2,4,7-Trioxo-1,2,3,4,7,8-Hexahydropyrido[2,3-d]pyrimidin-5-ylamino]phenyl}acetamide product and how it can benefit your pharmaceutical applications, please contact us today.